Crsp analyst ratings
Web23 hours ago · CRSP +14.8% + Free Alerts with an Overweight rating and a price target of $72, citing an interesting gene editing play for 2024. The company has an excellent … WebApr 13, 2024 · Shares of CRISPR Therapeutics AG ( NASDAQ:CRSP - Get Rating) have received a consensus rating of "Hold" from the twenty analysts that are presently …
Crsp analyst ratings
Did you know?
Web5 rows · See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, ... Find the latest CRISPR Therapeutics AG (CRSP) stock discussion in Yahoo … Interactive Chart for CRISPR Therapeutics AG (CRSP), analyze all the data with a … Get the detailed quarterly/annual income statement for CRISPR Therapeutics AG … Discover historical prices for CRSP stock on Yahoo Finance. View daily, weekly or … See the company profile for CRISPR Therapeutics AG (CRSP) including … See CRISPR Therapeutics AG (CRSP) Environment, Social and Governance … Find out all the key statistics for CRISPR Therapeutics AG (CRSP), including … Find out the direct holders, institutional holders and mutual fund holders for … View the basic CRSP option chain and compare options of CRISPR … WebApr 3, 2024 · Crispr Therapeutics AG (CRSP) In a report released today, Anthony Butler from EF Hutton reiterated a Buy rating on Crispr Therapeutics AG, with a price target of $75.00. The company’s shares ...
Web20 hours ago · Cathie Wood Buys CRSP Stock Before Cantor Price Target Initiation. Cantor analyst Olivia Brayer has initiated coverage of Crispr with an “overweight” rating and a price target of $72. WebCRSP Analyst Ratings Moderate Buy 17 Ratings 9 Buy 7 Hold 1 Sell Based on 17 analysts giving stock ratings to Crispr Therapeutics AG in the past 3 months CRSP …
WebCRSP will report Q1 2024 earnings on 05/09/2024 EPS Surprise Estimate Actual Q1 2024 Q2 2024 Q3 2024 Q4 2024 -3 -2 -1 Analyst Ratings Upgrades/Downgrades View All Upgrades & Downgrades FY...
Web1 day ago · Upgrades. UBS upgraded the previous rating for Ingredion Inc INGR from Neutral to Buy. For the fourth quarter, Ingredion had an EPS of $1.65, compared to year-ago quarter EPS of $1.09.
Web2 days ago · CRISPR Therapeutics (CRSP) (Delayed Data from NSDQ) $44.80 USD +1.09 (2.49%) Updated Apr 5, 2024 03:59 PM ET After-Market: $44.60 -0.20 (-0.45%) 7:58 PM ET Add to portfolio Zacks Rank: 2-Buy 2... black walnut buyers in kyWeb2 days ago · View real-time CRSP stock price and news, along with industry-best analysis. ... Analyst Ratings. Average price target from 29 ratings: $78.76. ... Fundamental … fox news alabama election resultsWebApr 11, 2024 · View CRSP analyst ratings or view top-rated stocks. What is CRISPR Therapeutics' stock price forecast for 2024? 18 Wall Street analysts have issued 12-month price objectives for CRISPR … black walnut buyersWebApr 14, 2024 · InvestorsObserver is giving Crispr Therapeutics AG (CRSP) an Analyst Rating Rank of 33, meaning CRSP is ranked higher by analysts than 33% of stocks. The average price target for CRSP is $87.24 and analyst’s rate the stock as a Buy. Wall Street analysts are rating CRSP a Buy today. Find out what this means to you and get the rest … fox news alabama governorWebCRSP CRISPR Therapeutics AG Analyst Estimates & Rating – WSJ CRISPR Therapeutics AG CRSP (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT … black walnut buyers wisconsinWebMar 21, 2024 · According to 11 analyst offering 12-month price targets in the last 3 months, CRISPR Therapeutics has an average price target of $71.91 with a high of $123.00 and … fox news alWebApr 12, 2024 · The number of analysts that have assigned CRSP a recommendation rating is 29. Out of them, 12 rate it a Hold, while 15 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst (s) have tagged CRISPR Therapeutics AG (CRSP) as Underweight, while 2 advise Sell. fox newsaking news